ARHGAP30 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
natural killer cell	36 studies	31% ± 9%	Explore
CD8-positive, alpha-beta T cell	32 studies	27% ± 9%	Explore
CD4-positive, alpha-beta T cell	26 studies	25% ± 7%	Explore
B cell	23 studies	23% ± 6%	Explore
T cell	23 studies	27% ± 11%	Explore
regulatory T cell	23 studies	26% ± 8%	Explore
non-classical monocyte	22 studies	33% ± 14%	Explore
classical monocyte	22 studies	31% ± 14%	Explore
mature NK T cell	18 studies	28% ± 9%	Explore
macrophage	18 studies	23% ± 7%	Explore
gamma-delta T cell	18 studies	29% ± 9%	Explore
monocyte	17 studies	27% ± 8%	Explore
memory B cell	17 studies	21% ± 3%	Explore
conventional dendritic cell	16 studies	28% ± 16%	Explore
CD16-positive, CD56-dim natural killer cell, human	15 studies	34% ± 10%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	15 studies	24% ± 7%	Explore
naive B cell	15 studies	19% ± 3%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	14 studies	27% ± 9%	Explore
CD16-negative, CD56-bright natural killer cell, human	14 studies	29% ± 8%	Explore
CD8-positive, alpha-beta memory T cell	13 studies	30% ± 10%	Explore
dendritic cell	12 studies	31% ± 16%	Explore
mucosal invariant T cell	12 studies	27% ± 7%	Explore
CD4-positive, alpha-beta memory T cell	11 studies	26% ± 8%	Explore
effector memory CD8-positive, alpha-beta T cell	10 studies	30% ± 9%	Explore
plasmacytoid dendritic cell	9 studies	23% ± 5%	Explore
effector CD8-positive, alpha-beta T cell	7 studies	30% ± 8%	Explore
myeloid cell	7 studies	28% ± 9%	Explore
neutrophil	6 studies	21% ± 6%	Explore
T follicular helper cell	6 studies	22% ± 3%	Explore
exhausted T cell	5 studies	39% ± 12%	Explore
lymphocyte	5 studies	28% ± 6%	Explore
innate lymphoid cell	5 studies	24% ± 7%	Explore
effector memory CD4-positive, alpha-beta T cell	5 studies	33% ± 9%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	28% ± 8%	Explore
leukocyte	4 studies	23% ± 2%	Explore
hematopoietic precursor cell	4 studies	24% ± 2%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	36% ± 6%	Explore
alveolar macrophage	4 studies	24% ± 9%	Explore
T-helper 17 cell	4 studies	25% ± 3%	Explore
double negative thymocyte	4 studies	31% ± 2%	Explore
plasmablast	3 studies	36% ± 12%	Explore
epithelial cell	3 studies	21% ± 8%	Explore
immature B cell	3 studies	22% ± 3%	Explore
CD4-positive helper T cell	3 studies	19% ± 4%	Explore
group 3 innate lymphoid cell	3 studies	26% ± 11%	Explore
T-helper 1 cell	3 studies	32% ± 3%	Explore
central memory CD4-positive, alpha-beta T cell	3 studies	26% ± 4%	Explore
central memory CD8-positive, alpha-beta T cell	3 studies	23% ± 5%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	18 studies	29% ± 9%	Explore
lung	3 studies	21% ± 5%	Explore
lymph node	3 studies	19% ± 3%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	100%	4512.58	577 / 578	98%	23.07	1129 / 1155
breast	84%	1086.80	385 / 459	98%	22.42	1099 / 1118
esophagus	68%	1276.59	978 / 1445	93%	12.48	171 / 183
bladder	67%	997.57	14 / 21	93%	17.62	468 / 504
skin	72%	2940.93	1301 / 1809	86%	23.87	408 / 472
prostate	72%	759.40	176 / 245	81%	8.00	407 / 502
intestine	70%	1822.88	675 / 966	78%	11.85	413 / 527
stomach	63%	693.72	227 / 359	83%	13.28	238 / 286
uterus	37%	318.36	63 / 170	90%	17.31	414 / 459
kidney	38%	550.26	34 / 89	88%	19.66	791 / 901
thymus	40%	558.95	260 / 653	85%	22.95	514 / 605
adrenal gland	76%	826.29	195 / 258	33%	2.66	77 / 230
brain	14%	126.03	367 / 2642	93%	14.17	657 / 705
pancreas	13%	131.61	42 / 328	94%	22.81	167 / 178
lymph node	0%	0	0 / 0	100%	195.40	29 / 29
peripheral blood	100%	24543.09	929 / 929	0%	0	0 / 0
spleen	100%	15998.46	241 / 241	0%	0	0 / 0
ureter	0%	0	0 / 0	100%	23.91	1 / 1
ovary	11%	104.05	20 / 180	86%	9.87	370 / 430
tonsil	0%	0	0 / 0	96%	32.97	43 / 45
adipose	92%	1562.14	1109 / 1204	0%	0	0 / 0
liver	31%	279.66	69 / 226	57%	6.54	231 / 406
blood vessel	42%	620.86	565 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	30%	3.14	24 / 80
heart	21%	189.58	179 / 861	0%	0	0 / 0
muscle	1%	10.77	12 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0051056	Biological process	regulation of small GTPase mediated signal transduction
GO_0007264	Biological process	small GTPase-mediated signal transduction
GO_0043231	Cellular component	intracellular membrane-bounded organelle
GO_0005829	Cellular component	cytosol
GO_0031410	Cellular component	cytoplasmic vesicle
GO_0005515	Molecular function	protein binding
GO_0005096	Molecular function	GTPase activator activity

IV. Literature review

[source]

Gene name	ARHGAP30
Protein name	Rho GTPase-activating protein 30 (Rho-type GTPase-activating protein 30) Alternative protein ARHGAP30 Rho GTPase activating protein 30
Synonyms
Description	FUNCTION: GTPase-activating protein (GAP) for RAC1 and RHOA, but not for CDC42. .
Accessions	Q7Z6I6 ENST00000490279.5 ENST00000368013.8 [Q7Z6I6-1] ENST00000368015.1 ENST00000368016.7 A0A0A0MRJ9 ENST00000471492.2 E9PLA4 A0A0A0MRJ8 E9PAN4 E9PLT5 ENST00000368018.2 L0R4U0

ARHGAP30 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review